IGF1 and Alzheimer disease: A chitosan hydrogel functionalised with an insulin-like growth factor 1 C-terminal (IGF-1C) peptide was shown to provide an artificial microenvironment that significantly enhances the survival and functionality of AD–MSCs (Feng et al., 2016).